Akinori Ueda
Stock Analyst at Goldman Sachs
(1.87)
# 7,689
Out of 12,268 analysts
37
Total ratings
34.6%
Success rate
0.6%
Average return
Main Sectors:
Stocks Rated by Akinori Ueda
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| TYO: 4578 Otsuka Holdings Co., Ltd. | Maintained: Buy | $11,900 → $12,400 | $11,395.00 | +8.82% | 9 | Apr 30, 2026 | |
| TYO: 4568 Daiichi Sankyo Company, Limited | Rated: Buy | $4,900 → $4,300 | $2,699.50 | +59.29% | 3 | Apr 15, 2026 | |
| TYO: 2413 M3, Inc. | Rated: Hold | $2,300 → $2,050 | $1,398.50 | +46.59% | 3 | Apr 15, 2026 | |
| TYO: 4507 Shionogi & Co., Ltd. | Initiated Coverage: Hold | $3,300 | $3,009.00 | +9.67% | 1 | Apr 8, 2026 | |
| TYO: 4587 PeptiDream Inc. | Maintained: Buy | $3,000 → $2,750 | $1,193.50 | +130.41% | 4 | Feb 17, 2026 | |
| TYO: 6869 Sysmex Corporation | Maintained: Buy | $2,400 → $2,000 | $1,367.50 | +46.25% | 2 | Feb 13, 2026 | |
| TYO: 4151 Kyowa Kirin Co., Ltd. | Downgraded: Sell | $2,500 → $2,250 | $2,406.50 | -6.50% | 4 | Dec 16, 2025 | |
| TYO: 7733 Olympus Corporation | Maintained: Buy | $2,200 | $1,777.50 | +23.77% | 3 | Jul 25, 2025 | |
| ALKS Alkermes | Reiterated: Buy | $40 | $36.80 | n/a | 1 | Jul 19, 2023 | |
| TYO: 4502 Takeda Pharmaceutical Company Limited | Downgraded: Hold | $3,700 | $5,046.00 | n/a | 1 | Jan 13, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $5,000 | $2,333.00 | n/a | 1 | Dec 21, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | n/a | $4,000.00 | n/a | 1 | Jun 16, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | n/a | $16.25 | n/a | 2 | Apr 19, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgraded: Buy | n/a | $11.83 | n/a | 1 | Dec 20, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | n/a | $2,226.00 | n/a | 1 | Jun 8, 2018 |
Otsuka Holdings Co., Ltd.
Apr 30, 2026
Maintained: Buy
Price Target: $11,900 → $12,400
Current: $11,395.00
Upside: +8.82%
Daiichi Sankyo Company, Limited
Apr 15, 2026
Rated: Buy
Price Target: $4,900 → $4,300
Current: $2,699.50
Upside: +59.29%
M3, Inc.
Apr 15, 2026
Rated: Hold
Price Target: $2,300 → $2,050
Current: $1,398.50
Upside: +46.59%
Shionogi & Co., Ltd.
Apr 8, 2026
Initiated Coverage: Hold
Price Target: $3,300
Current: $3,009.00
Upside: +9.67%
PeptiDream Inc.
Feb 17, 2026
Maintained: Buy
Price Target: $3,000 → $2,750
Current: $1,193.50
Upside: +130.41%
Sysmex Corporation
Feb 13, 2026
Maintained: Buy
Price Target: $2,400 → $2,000
Current: $1,367.50
Upside: +46.25%
Kyowa Kirin Co., Ltd.
Dec 16, 2025
Downgraded: Sell
Price Target: $2,500 → $2,250
Current: $2,406.50
Upside: -6.50%
Olympus Corporation
Jul 25, 2025
Maintained: Buy
Price Target: $2,200
Current: $1,777.50
Upside: +23.77%
Alkermes
Jul 19, 2023
Reiterated: Buy
Price Target: $40
Current: $36.80
Upside: n/a
Takeda Pharmaceutical Company Limited
Jan 13, 2022
Downgraded: Hold
Price Target: $3,700
Current: $5,046.00
Upside: n/a
Dec 21, 2021
Reiterated: Hold
Price Target: $5,000
Current: $2,333.00
Upside: n/a
Jun 16, 2021
Maintained: Hold
Price Target: n/a
Current: $4,000.00
Upside: n/a
Apr 19, 2021
Maintained: Buy
Price Target: n/a
Current: $16.25
Upside: n/a
Dec 20, 2018
Upgraded: Buy
Price Target: n/a
Current: $11.83
Upside: n/a
Jun 8, 2018
Downgraded: Hold
Price Target: n/a
Current: $2,226.00
Upside: n/a